Control of HCV Infection by Natural Killer Cells and Macrophages
Overview
Authors
Affiliations
Host defense against invading pathogens within the liver is dominated by innate immunity. Natural killer (NK) cells have been implicated at all stages of hepatitis C virus (HCV) infection, from providing innate protection to contributing to treatment-induced clearance. Decreased NK cell levels, altered NK cell subset distribution, activation marker expression, and functional polarization toward a cytolytic phenotype are hallmarks of chronic HCV infection. Interferon α (IFN-α) is a potent activator of NK cells; therefore, it is not surprising that NK cell activation has been identified as a key factor associated with sustained virological response (SVR) to IFN-α-based therapies. Understanding the role of NK cells, macrophages, and other innate immune cells post-SVR remains paramount for prevention of disease pathogenesis and progression. Novel strategies to treat liver disease may be aimed at targeting these cells.
Contemporary Insights into Hepatitis C Virus: A Comprehensive Review.
Sallam M, Khalil R Microorganisms. 2024; 12(6).
PMID: 38930417 PMC: 11205832. DOI: 10.3390/microorganisms12061035.
Huang C, Awad M, Gal-Tanamy M, Yu M Clin Mol Hepatol. 2024; 30(3):326-344.
PMID: 38665034 PMC: 11261227. DOI: 10.3350/cmh.2024.0155.
Unraveling the role of the liver myeloid compartment during hepatitis C virus cure.
Crouchet E, Baumert T J Hepatol. 2023; 80(2):184-187.
PMID: 37088307 PMC: 7615597. DOI: 10.1016/j.jhep.2023.04.016.
Etiology of end-stage liver cirrhosis impacts hepatic natural killer cell heterogenicity.
Maretti-Mira A, Salomon M, Hsu A, Dara L, Golden-Mason L Front Immunol. 2023; 14:1137034.
PMID: 37063898 PMC: 10098346. DOI: 10.3389/fimmu.2023.1137034.
Carreca A, Gaetani M, Busa R, Francipane M, Gulotta M, Perricone U Viruses. 2022; 14(7).
PMID: 35891518 PMC: 9317111. DOI: 10.3390/v14071538.